Skip Content
You are currently on the new version of our website. Access the old version .

Vaccines, Volume 6, Issue 3

2018 September - 31 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (31)

  • Review
  • Open Access
14 Citations
5,769 Views
10 Pages

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

  • Thomas J. Van Ee,
  • Heleen H. Van Acker,
  • Tom G. Van Oorschot,
  • Viggo F. Van Tendeloo,
  • Evelien L. Smits,
  • Ghaith Bakdash,
  • Gerty Schreibelt and
  • I. Jolanda M. De Vries

19 September 2018

Dendritic cell (DC) vaccines show promising effects in cancer immunotherapy. However, their efficacy is affected by a number of factors, including (1) the quality of the DC vaccine and (2) tumor immune evasion. The recently characterized BDCA1+CD14+...

  • Review
  • Open Access
214 Citations
15,691 Views
23 Pages

Cathelicidins: Immunomodulatory Antimicrobials

  • Roel M. Van Harten,
  • Esther Van Woudenbergh,
  • Albert Van Dijk and
  • Henk P. Haagsman

14 September 2018

Cathelicidins are host defense peptides with antimicrobial and immunomodulatory functions. These effector molecules of the innate immune system of many vertebrates are diverse in their amino acid sequence but share physicochemical characteristics lik...

  • Article
  • Open Access
20 Citations
8,501 Views
20 Pages

A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies

  • Sun-Young Sunwoo,
  • Michael Schotsaert,
  • Igor Morozov,
  • Anne Sally Davis,
  • Yuhao Li,
  • Jinhwa Lee,
  • Chester McDowell,
  • Philip Meade,
  • Raffael Nachbagauer and
  • Juergen A. Richt
  • + 3 authors

14 September 2018

The antigenically conserved hemagglutinin stalk region is a target for universal influenza virus vaccines since antibodies against it can provide broad protection against influenza viruses of different subtypes. We tested a universal influenza virus...

  • Review
  • Open Access
19 Citations
11,056 Views
13 Pages

Zika Virus Vaccines: Challenges and Perspectives

  • Raquel Das Neves Almeida,
  • Trina Racine,
  • Kelly G. Magalhães and
  • Gary P. Kobinger

13 September 2018

Zika virus is an arbovirus that has rapidly spread within the Americas since 2014, presenting a variety of clinical manifestations and neurological complications resulting in congenital malformation, microcephaly, and possibly, in male infertility. T...

  • Review
  • Open Access
111 Citations
14,892 Views
8 Pages

8 September 2018

Cervical cancer is a critical public health issue in sub-Saharan Africa (SSA), where it is the second leading cause of cancer among women and the leading cause of female cancer deaths. Incidence and mortality rates are substantially higher than in hi...

  • Article
  • Open Access
57 Citations
9,844 Views
17 Pages

4 September 2018

Neisseria gonorrhoeae is a strict human pathogen responsible for more than 100 million new sexually transmitted infections worldwide each year. Due to the global emergence of antibiotic resistance, the Center for Disease control (CDC) recently listed...

  • Article
  • Open Access
35 Citations
5,362 Views
12 Pages

31 August 2018

The relative burden of community-acquired pneumonia (CAP) in older adults (≥65 years old) compared to other serious diseases is important to prioritize preventive treatment. A retrospective analysis was conducted using the 2014 National Readmissio...

  • Review
  • Open Access
27 Citations
11,414 Views
15 Pages

30 August 2018

For centuries, the development of vaccines to prevent infectious disease was an empirical process. From smallpox variolation in Song dynasty China, through the polysaccharide capsule vaccines developed in the 1970s, vaccines were made either from the...

  • Article
  • Open Access
16 Citations
4,721 Views
15 Pages

β-Defensins Coordinate In Vivo to Inhibit Bacterial Infections of the Trachea

  • Lisa Kathleen Ryan,
  • Jichuan Wu,
  • Kyell Schwartz,
  • Sunghan Yim and
  • Gill Diamond

28 August 2018

β-defensins are predicted to play an important role in innate immunity against bacterial infections in the airway. We previously observed that a type III-secretion product of Bordetella bronchiseptica inhibits the NF-κB-mediated induction...

  • Review
  • Open Access
9 Citations
5,248 Views
10 Pages

25 August 2018

Endometrial stromal sarcomas are a subtype of uterine sarcomas that are characterized by recurrent chromosomal translocations, resulting in the expression of tumor-specific fusion proteins that contribute to their tumorigenicity. These characteristic...

  • Review
  • Open Access
10 Citations
4,799 Views
11 Pages

Therapeutic Vaccines for Genitourinary Malignancies

  • Giselle M. A. Dutcher and
  • Mehmet Asim Bilen

12 August 2018

The field of genitourinary malignancies has been a showcase for therapeutic cancer vaccine success since the application of intravesicular Bacillus Calmette-Guerin (BCG) for bladder cancer in the 1970s and enjoyed a renaissance in 2010 with the US Fo...

  • Review
  • Open Access
19 Citations
8,049 Views
12 Pages

10 August 2018

Initial attempts to develop monoclonal antibodies as therapeutics to resolve influenza infections focused mainly on searching for antibodies with the potential to neutralise the virus in vitro with classical haemagglutination inhibition and microneut...

  • Review
  • Open Access
39 Citations
8,592 Views
16 Pages

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis

  • Anusha Thadi,
  • Marian Khalili,
  • William F. Morano,
  • Scott D. Richard,
  • Steven C. Katz and
  • Wilbur B. Bowne

10 August 2018

Peritoneal metastasis (PM) is an advanced stage malignancy largely refractory to modern therapy. Intraperitoneal (IP) immunotherapy offers a novel approach for the control of regional disease of the peritoneal cavity by breaking immune tolerance. The...

  • Review
  • Open Access
28 Citations
6,042 Views
17 Pages

Next Generation Cancer Vaccines—Make It Personal!

  • Angelika Terbuch and
  • Juanita Lopez

Dramatic success in cancer immunotherapy has been achieved over the last decade with the introduction of checkpoint inhibitors, leading to response rates higher than with chemotherapy in certain cancer types. These responses are often restricted to c...

  • Article
  • Open Access
17 Citations
6,069 Views
13 Pages

Antimicrobial peptides, also known as host defence peptides, are immunomodulatory molecules required to resolve infections. Antimicrobial peptides and proteins (APPs) are important in the control of infections in the lungs. Despite evidence that APPs...

  • Article
  • Open Access
67 Citations
16,206 Views
19 Pages

Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials

  • Georgina Bowyer,
  • Tommy Rampling,
  • Jonathan Powlson,
  • Richard Morter,
  • Daniel Wright,
  • Adrian V.S. Hill and
  • Katie J. Ewer

Immunogenicity of T cell-inducing vaccines, such as viral vectors or DNA vaccines and Bacillus Calmette-Guérin (BCG), are frequently assessed by cytokine-based approaches. While these are sensitive methods that have shown correlates of protection in...

  • Review
  • Open Access
8 Citations
5,762 Views
17 Pages

Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases

  • Anne M. Van der Does,
  • Gimano D. Amatngalim,
  • Bart Keijser,
  • Pieter S. Hiemstra and
  • Remi Villenave

The respiratory tract harbours a variety of microorganisms, collectively called the respiratory microbiota. Over the past few years, alterations in respiratory and gut microbiota composition have been associated with chronic inflammatory diseases of...

  • Review
  • Open Access
39 Citations
8,769 Views
16 Pages

Avian Influenza A Virus Pandemic Preparedness and Vaccine Development

  • Rory D. De Vries,
  • Sander Herfst and
  • Mathilde Richard

Influenza A viruses can infect a wide range of hosts, creating opportunities for zoonotic transmission, i.e., transmission from animals to humans, and placing the human population at constant risk of potential pandemics. In the last hundred years, fo...

  • Article
  • Open Access
32 Citations
6,034 Views
11 Pages

Influenza viruses cause severe diseases and mortality in humans on an annual basis. The current influenza virus vaccines can confer protection when they are well-matched with the circulating strains. However, due to constant changes of the virus surf...

  • Review
  • Open Access
114 Citations
15,851 Views
19 Pages

Listeria monocytogenes, a Gram-positive facultative anaerobic bacterium, is becoming a popular vector for cancer immunotherapy. Indeed, multiple vaccines have been developed utilizing modified Listeria as a tool for generating immune responses agains...

  • Review
  • Open Access
36 Citations
17,735 Views
19 Pages

Salmonella enterica serovar Typhi (S. Typhi) and S. Paratyphi, namely typhoidal Salmonellae, are the cause of (para) typhoid fever, which is a devastating systemic infectious disease in humans. In addition, the spread of multidrug-resistant (MDR) and...

  • Article
  • Open Access
17 Citations
5,590 Views
11 Pages

Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?

  • Maelíosa T. C. McCrudden,
  • Katherine O’Donnell,
  • Chris R. Irwin and
  • Fionnuala T. Lundy

Mounting evidence suggests that the host defence peptide, LL-37, plays a role in both inflammation and in wound healing; however, the role of this peptide in the remodeling and maintenance of oral tissues is not yet fully understood. Fibroblasts are...

  • Review
  • Open Access
27 Citations
13,295 Views
17 Pages

The development of effective vaccines continues to be a key goal for public health bodies, governments, funding bodies and pharmaceutical companies. With new vaccines such as Shingrix targeting Shingles and Bexsero for Meningitis B, licensed in recen...

  • Article
  • Open Access
8 Citations
5,470 Views
17 Pages

Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs

  • Dafni Chondronasiou,
  • Tracy-Jane T. H. D. Eisden,
  • Anita G. M. Stam,
  • Qiana L. Matthews,
  • Mert Icyuz,
  • Erik Hooijberg,
  • Igor Dmitriev,
  • David T. Curiel,
  • Tanja D. De Gruijl and
  • Rieneke Van de Ven

To mount a strong anti-tumor immune response, non T cell inflamed (cold) tumors may require combination treatment encompassing vaccine strategies preceding checkpoint inhibition. In vivo targeted delivery of tumor-associated antigens (TAA) to dendrit...

  • Communication
  • Open Access
23 Citations
9,796 Views
13 Pages

Pulmonary delivery of drugs and vaccines is an established route of administration, with particulate-based carriers becoming an attractive strategy to enhance the benefits of pulmonary therapeutic delivery. Despite the increasing number of publicatio...

  • Article
  • Open Access
1 Citations
4,746 Views
13 Pages

Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells

  • Xiaofang Xiong,
  • Jugal Kishor Das,
  • Jianyong Song,
  • Bing Ni,
  • Xingcong Ren,
  • Jin-Ming Yang and
  • Jianxun Song

Hematopoietic stem cells (HSCs) yield both the myeloid and lymphoid lineages of blood cells and can be reprogrammed into tumor antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) to prevent tumor growth. However, the optimal approach for differ...

  • Article
  • Open Access
12 Citations
6,550 Views
19 Pages

The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination

  • Ewan P. Plant,
  • Angelia A. Eick-Cost,
  • Hussein Ezzeldin,
  • Jose L. Sanchez,
  • Zhiping Ye and
  • Michael J. Cooper

The first exposure to influenza is thought to impact subsequent immune responses later in life. The consequences of this can be seen during influenza epidemics and pandemics with differences in morbidity and mortality for different birth cohorts. The...

  • Review
  • Open Access
155 Citations
14,330 Views
12 Pages

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System

  • Mona O. Mohsen,
  • Ariane C. Gomes,
  • Monique Vogel and
  • Martin F. Bachmann

Virus-like particles (VLPs) derived from viral nucleocapsids are an important class of nanoparticles. The structure, uniformity, stability, and function of these VLPs have attracted scientists in utilizing them as a unique tool in various application...

  • Article
  • Open Access
11 Citations
5,709 Views
17 Pages

The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain

  • Romain Paillot,
  • Dion Garrett,
  • Maria R. Lopez-Alvarez,
  • Ihlan Birand,
  • Fernando Montesso and
  • Linda Horspool

Vaccination is one of the most effective tools for limiting the impact of equine influenza (EI). The humoral immunity established following a primary vaccination course can decrease significantly between the second (V2) and third immunisations (V3),...

  • Review
  • Open Access
31 Citations
8,798 Views
10 Pages

Recent studies have revealed multiple roles for Fc gamma receptors (FcγRs) in broad immunity against influenza viruses. Activating FcγR pathways can be harnessed to confer protection mediated by non-neutralizing anti-HA IgGs and to increa...

  • Review
  • Open Access
13 Citations
6,937 Views
14 Pages

Hemagglutinin (HA) of influenza virus is a major target for vaccines. HA initiates the internalization of the virus into the host cell by binding to host sialic acid receptors; therefore, inhibition of HA can significantly prevent influenza virus inf...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X